Watch Blueprint Medicines Videos

Blueprint Medicines CEO on $1.7 billion cancer drug partnership with Roche

Sanofi Buys Blueprint Medicines for $9.1 Billion

Founder Stories: Christoph Lengauer, Thrive Earlier Detection and Blueprint Medicines

Labiotech Tour Boston 2014: Blueprint Medicines with CSO, Christoph Lengauer

Sanofi Strengthens Drug Pipeline Through Blueprint $9.1 Billion Acquisition

Blueprint Medicine | Suki Tipp & Pankit Vachhani | Daily Flash

Blueprint Medicines: May 2019

Blueprint Medicines: $2B+ Opportunity Ahead? Fireside Chat with COO & R&D President | Needham 2025

Kate Haviland '98 on Her Wesleyan Journey

Blueprint Medicines GIST Trials: Avapritinib update for the GIST patient and caregiver community

BLUEPRINT MEDICINES. SANOFI BUY BLUEPRINT MEDICINES AT ABSURD VALUATION ! #sanofi #2025 #nasdaq

Why Blueprint Medicines stock deserves to be in your portfolio in 2024? | Blueprint Medicines Corp.

🔬 Blueprint Medicines: Biotech Breakthroughs & Future Growth | H.C. Wainwright Conference 2025

Sanofi-Blueprint deal is a bullish signal about biotech M&A

ASCO 2021 - Blueprint Medicines - ARROW Study Updated Results

Blueprint Medicine: The Toll

BPMC, Blueprint Medicines Corporation, 2025-01-13, stock prices and MACD indicators #MACD #BPMC

How Blueprint Medicines Leverages the Kwello Platform

The Efficacy of Avapritinib to Treat Advanced Systemic Mastocytosis

Drug Development Panel